M
Murray Krahn
Researcher at University of Toronto
Publications - 52
Citations - 7805
Murray Krahn is an academic researcher from University of Toronto. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 28, co-authored 33 publications receiving 6867 citations. Previous affiliations of Murray Krahn include Sunnybrook Health Sciences Centre & University Health Network.
Papers
More filters
Journal ArticleDOI
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine
Gillian D Sanders,Peter J. Neumann,Anirban Basu,Dan W. Brock,David Feeny,Murray Krahn,Karen M. Kuntz,David O. Meltzer,Douglas K Owens,Lisa A. Prosser,Joshua A. Salomon,Mark Sculpher,Thomas A Trikalinos,Louise B. Russell,Joanna E. Siegel,Theodore G. Ganiats +15 more
TL;DR: The Second Panel on Cost-Effectiveness in Health and Medicine reviewed the current status of the field of cost-effectiveness analysis and developed a new set of recommendations, including the recommendation to perform analyses from 2 reference case perspectives and to provide an impact inventory to clarify included consequences.
Journal ArticleDOI
Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression†
TL;DR: A large systematic review of published prognostic studies provides increased precision in estimating fibrosis progression in chronic HCV infection and supports nonlinear disease progression.
Journal ArticleDOI
Screening for prostate cancer. A decision analytic view.
Murray Krahn,John E. Mahoney,Mark H. Eckman,John Trachtenberg,Stephen G. Pauker,Allan S. Detsky +5 more
TL;DR: The analysis does not support using PSA, TRUS, or DRE to screen asymptomatic men for prostatic cancer, and Screening may result in poorer health outcomes and will increase costs dramatically.
Journal ArticleDOI
Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis.
TL;DR: The results confirm that chronic hepatitis C outcomes are worse among coinfected individuals, and HAART did not appear to fully correct the adverse effect of HIV infection on HCV prognosis.
Journal ArticleDOI
Conceptualizing a Model A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force–2
Mark S. Roberts,Louise B. Russell,A. David Paltiel,Michael Chambers,Phil McEwan,Murray Krahn +5 more
TL;DR: A series of consensus-based best practices regarding the process of model conceptualization, which matches the attributes and characteristics of a particular modeling type to the needs of the problem being represented, are provided.